HomeGeneris

Generis

2 of 3 Leading COVID-19 Vaccine Initiatives utilizing Generis’s Life Science Platform, CARA

The company reports the US-driven international initiative to support the rapid development, manufacturing, and distribution of COVID-19 vaccines is progressing with many promising efforts to move towards Phase 3 clinical trials.